Update on the management of skin, soft-tissue, and osteoarticular infections in children

Current Opinion in Pediatrics

Volumn 18, Issue 3, 2006, Pages 254-259

  Tien, Irene ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Kingella kingae; Methicillin resistant staphylococcus aureus; Osteomyelitis; Septic arthritis; Skin and soft tissue infections

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; NAFCILLIN; PENICILLIN G; PSEUDOMONIC ACID; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; CHILD; EQUIPMENT; HUMAN; INOCULATION; KINGELLA KINGAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOARTHROPATHY; PRIORITY JOURNAL; REVIEW; SKIN DECONTAMINATION; SKIN INFECTION; SOFT TISSUE INFECTION; SYNOVIAL FLUID; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BONE DISEASES, INFECTIOUS; CHILD; HUMANS; METHICILLIN RESISTANCE; NEISSERIACEAE INFECTIONS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 33744829258     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000193308.45333.11     Document Type: Review

References (72)

1. Frank G, Mahoney HM, Eppes SC. Musculoskeletal infections in children. Pediatr Clin N Am 2005; 52:1083-1106. A review article that discusses osteomyelitis, septic arthritis, pyomyositis, and necrotizing fasciitis in children.
2. Gutierrez K. Bone and joint infections in children. Pediatr Clin N Am 2005; 52:779-794. A review article that discusses osteomyelitis and septic arthritis in children.
3. Swartz MN. Cellulitis. N Engl J Med 2004; 350:904-912.
4. Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 1998; 17:745-746.
5. Cohen PR, Kurzrock R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. J A Acad Dermatol 2004; 50:277-280.
6. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436-1444. The results of an MRSA surveillance study of adults and children in Baltimore and Atlanta are given.
7. Johnigan RH, Pereira KD, Poole MD. Community acquired methicillin resistant Staphylococcus aureus in children and adolescents. Arch Otolaryngol Head Neck Surg 2003; 129:1049-1052.
8. Cohen PR, Kurzrock R. Community acquired methicillin resistant Staphylococcus aureus skin infections: an emerging clinical problem. Amer Acad Derm 2004; 50:277-280.
9. Dietrich DW, Auld DB, Mermel LA. Community acquired methicillin resistant Staphylococcus aureus in southern New England. Pediatrics 2004; 113:e347-e352.
10. Frazee BW, Lynn J, Charlebois ED, et al. High prevalence of the methicillin resistant Staphylococcus aureus in emergency department skin infection and soft tissue infections. Ann Emerg Med 2005; 45:311-320. A prospective, observational study of causes of SSTIs in adults presenting to an urban emergency department.
11. Baggett HC, Hennessy TW, Rudolph K, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004; 189:1565-1573.
12. Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39:47-54.
13. Leman R, Alvarado-Ramy F, Pocock S, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus in an American Indian population. Infect Control Hosp Epidemiol 2004; 25:121-125.
14. Kaplan SL. Implications of methicillin resistant Staphylococcus aureus as a community acquired pathogen in pediatric patients. Infect Dis Clin N Am 2005; 19:747-757. A review of the literature on CA-MRSA in children.
15. Ochoa TJ, Mohr J, Wanger A, et al. Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerg Infect Dis 2005; 11:966-968. A retrospective chart review on children who tested positive for CA-MRSA or CA-MSSA, including prevalence, clinical characteristics, susceptibility patterns, and empiric antimicrobial regimens.
16. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005; 11:928-930. A retrospective review of adults who presented to an urban emergency department with a SSTI and tested positive for CA-MRSA.
17. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. CID 2005; 40:1785-1791. The results of prospective surveillance of children for MSRA at Texas Children's Hospital carried out between 2001 and 2004.
18. Buckingham SC, McDougal LK, Cathey LD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee children's hospital. Pediatr Inf Dis J 2004; 23:619-624.
19. Crawford SE, Daum RS. Epidemic community-associated methicillin-resistant Staphylococcus aureus: modern times for an ancient pathogen. Pediatr Infect Dis J 2005; 24:459-460. Review of the molecular genetics, spread, and clinical manifestations of CA-MRSA.
20. Zetola N, Francis JS, Nuermberger, Bishai W. Community acquired methicillin resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005; 5:275-286. A review of genetics, pathogenicity, diagnosis, and treatment of CA-MRSA.
21. Lindsay JA, Holden MT. Staphylococcus aureus: superbug, super genome? Trends Microbiol 2004; 12:378-385.
22. Holden MR, Feil EJ, Lindsay JA, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 2004; 101:9786-9791.
23. Melles DC, Gorkink RF, Boelens HA, et al. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 2004; 114:1732-1740.
24. Carleton AH, Diep BA, Charlebis ED, et al. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004; 190:1730-1738.
25. Chung M, Dickinson G, DeLencastre H, Tomasz A. International clones of methicillin-resistant Staphylococcus aureus in two hospitals in Miami, Florida. J Clin Microbiol 2004; 42:542-547.
26. Ma XX, Galiana A, Pedreira W, et al. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis 2005; 11:973-976. A retrospective analysis of patients presenting to two hospitals in Uruguay with CA-MRSA between 2002 and 2003.
27. Mishaan AMA, Mason E Jrs, Martinez-Aguilar G, et al. Emergence of a pre-dominant clone of community Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J 2005; 24:201-206. A retrospective analysis of the epidemiologic features of community-acquired S. aureus infections in children presenting to Texas Children's Hospital between 2001 and 2003.
28. Diep BA, Sensabaugh GF, Somboona NS, et al. Widespread skin and soft tissue infections caused by two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leukocidin. J Clin Microbiol 2004; 42:2080-2084.
29. Harbarth S, Francois P, Schrenzel J, et al. Community-associated methicillin-resistant Staphylococcus aureus, Switzerland. Emerg Infect Dis 2005; 11:962-965. A prospective, observational study of adults and children admitted to Geneva University Hospitals who were screened for MRSA carriage in 2003.
30. Barrett TW, Moran GJ. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants, Colorado, Indian, Pennsylvania, and Los Angeles County, 2000-2003. Ann Emerg Med 2004; 43:43-45.
31. Mulvey M, MacDougall L, Cholin B, et al. Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2005; 11:844-850. A prospective study of adults and children who presented for SSTI treatment health-care centers in Saskatchewan, Canada between 1999 and 2002.
32. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, et al. Community-acquired, methicillin-resistant Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23:706.
33. Yamasaki O, Kaneko J, Morizane S, et al. The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 2005; 40:381-385. A genetic evaluation of CA-MRSA isolates collected from adults and children with SSTIs taken at hospitals in Okayama, Japan between 1997 and 2002.
34. Liassine N, Auckenthaler R, Descombes MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol 2004; 42:825-828.
35. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-1453. A retrospective evaluation of wound cultures from necrotizing fasciitis that grew MRSA taken between 2003 and 2004 from adult patients presenting to Harbor-UCLA Medical Center.
36. Baker CJ, Frenck RW Jr. Change in the management of skin/soft tissue infections needed. AAP News 2004; 25:105.
37. Marcinak JF, Frank AL. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Curr Opin Infect Dis 2003; 16:265-269.
38. Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 2005; 24:457-458. A review of antimicrobial susceptibility of CA-MRSA and treatment recommendations. This review provides a very useful overview of CA-MRSA and considerations when deciding on treatment.
39. Lewis JS II, Jorgenson JH. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005; 40:280-285. A review of mechanism of, evaluation for, and clinical implications of inducible clindamycin resistance by CA-MRSA.
40. Lee MC, Rios AM, Aten MF, Mejias A, Cavouoti D, McCracken GH, Hardy D. Management and outcome of children with skin and soft tissue abscesses caused by community acquired methicillin resistant Staphylococcus aureus. Pediatr Infect Dis J 2004; 23:123-127.
41. Iyer S, Jones DH. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 2004; 50:854-858.
42. Chen SF. Staphylococcus aureus decolonization. Pediatr Infect Dis J 2005; 24:70-80. A review of literature examining efficacy of eradication of nasal colonization of S. aureus and implications for clinical infection.
43. Loeb M, Main C, Walkter-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2005 :4. A systematic review of literature evaluating eradication strategies for CA-MRSA.
44. Kiang KM, Ogunmodede F, Juni BA, et al. Outbreak of osteomyelitis/septic arthritis caused by Kingella kingae among child care attendees. Pediatrics 2005; 116:e206-e213. A prospective investigation into the source of K. kingae causing an outbreak of septic arthritis and osteomyelitis in two, and possibly three, toddlers in a daycare center. This paper provides an excellent overview of the literature and bibliography.
45. Chang WS, Chiu NC, Chi H, et al. Comparison of the characteristics of culture-negative compared with culture-positive septic arthritis in children. J Microbiol Immunol Infect 2005; 38:189-193. Retrospective comparison of culture negative and culture positive septic arthritis in a sample of children presenting to a hospital in Taiwan between 1984 and 2003.
46. Yagupsky P, Dagan R, Prajgrod F, Merires M. Respiratory carriage of Kingella kingae among healthy children. Pediatr Infect Dis J 1995; 14:673-678.
47. Floyed RL, Steele RW. Culture-negative osteomyelitis. Pediatr Infect Dis J 2003; 22:731-735.
48. Lyon RM, Evanich JD. Culture-negative septic arthritis in children. J Pediatr Orthop 1999; 19:655-659.
49. McCarthy JJ, Dormans JP, Kozin SH, Pizzutillo PD. Musculoskeletal infections in children: basic treatment principles and recent advancements. Instr Course Lect 2005; 54:515-528. A review of osteomyelitis, septic arthritis, cellulites, necrotizing fasciitis, diskitis, and soft-tissue infections of the hand in children.
50. Yagupsky P. Kingella kingae: from medical rarity to an emerging paediatric pathogen. Lancet Infect Dis 2004; 4:358-367.
51. Gene A, Garcia-Garcia JJ, Sala P, et al. Enhanced culture detection of Kingella kingae, a pathogen of increasing clinical importance in pediatrics. Pediatr Infect Dis J 2004; 23:886-888.
52. Slonim A, Walker ES, Mishori E, et al. Person-to-person transmission of Kingella kingae among day care center attendees. J Infect Dis 1998; 178:1843-1846.
53. Yagupsky P, Merires M, Bahar J, Dagan R. Respiratory carriage of Kingella kingae among healthy children. Pediatr Infect Dis J 1995; 14:673-678.
54. Yagupsky P, Katz O, Peled N. Antibiotic susceptibility of Kingella kingae isolates from respiratory carriers and patients with invasive infections. J Antimicrob Chemother 2001; 47:191-193.
55. Amir J, Yagupsky P. Invasive Kingella kingae infections associated with stomatitis in children. Pediatr Infect Dis J 1998; 17:757-758.
56. Yagupsky P, Peled N, Katz O. Epidemiological features of invasive Kingella kingae infections and respiratory carriage of the organism. J Clin Microbiol 2002; 40:4180-4184.
57. Claisson B, Falsen E, Kjellman B. Kingella kingae infection: a review and a presentation of data from 10 Swedish cases. Scand J Infect Dis 1995; 17:233-243.
58. Birgisson H, Steingrimsson O, Gudnason T. Kingella kingae infections in paediatric patients: 5 cases of septic arthritis, osteomyelitis and bacteremia. Scand J Infect Dis 1997; 29:495-498.
59. Goutzmanis JJ, Gonis G, Gilbert GL. Kingella kingae infection in children: ten cases and review of the literature. Pediatr Infect Dis J 1991; 10:677-683.
60. Lundy DW, Kehl DK. Increasing prevalence of Kingella kingae in osteoarticular infections in young children. J Pediatr Orthop 1998; 18:262-267.
61. Moylett EH, Rossmann SN, Epps HR, Demmler GJ. Importance of Kingella kingae as a pediatric pathogen in the United States. Pediatr Infect Dis J 2000; 19:263-265.
62. La Scola B, Iorgulescu I, Bollini G. Five cases of Kingella kingae skeletal infection in a French hospital. Eur J Clin Microbiol Infect Dis 1998; 17: 512-517.
63. Yagupsky P, Dagan R, Howard CB, et al. Clinical features and epidemiology of invasive Kingella kingae infections in southern Israel. Pediatrics 1993; 92: 800-804.
64. Yagupsky P, Bar-Ziv Y, Howard CB, Dagan R. Epidemiology, etiology, and clinical features of septic arthritis in children younger than 24 months. Arch Pediatr Adolesc Med 1995; 149:537-540.
65. Yagupsky P, Dagan R. Kingella kingae: an emerging cause of invasive infections in young children. Clin Infect Dis 1997; 24:860-866.
66. Strausbaugh L, Liedtke L, Hageman J, et al. Kingella kingae infections in children-United States, June 2001-November 2002. MMWR 2004; 53:244 (March).
67. Yagupsky P. Use of blood culture systems for isolation of Kingella kingae from synovial fluid. J Clin Microbiol 1999; 37:3785.
68. Lebjkowicz F, Cohn L, Hashman N, Kassis I. Recovery of Kingella kingae from blood and synovial fluid of two pediatric patients by using the BacT/Alert system. J Clin Microbiol 1999; 37:878.
69. Yagupsky P, Dagan R, Howard B, et al. High prevalence of Kingella kingae in joint fluid from children with septic arthritis revealed by the BACTEC blood culture system. J Clin Microbiol 1992; 30:1278-1281.
70. Yagupsky P, Press J. Use of the isolator 1.5 microbial tube for culture of synovial fluid from patients with septic arthritis. J Clin Microbiol 1997; 35:2410-2415.
71. Host B, Schumacher H, Prag J, Arpi M. Isolation of Kingella kingae from synovial fluids using commercial blood culture bottles. Eur J Clin Microbiol Infect Dis 2000; 19:608-611.
72. CDC. Osteomyelitis/septic arthritis caused by Kingella kingae among day care attendees-Minnesota, 2003. MMWR 2004; 53:241-243.